Jun-Ichi Hanatani, Koh Kitagawa, Fumimasa Tomooka, Shohei Asada, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Shinya Sato, Akihiko Shibamoto, Yuki Fujimoto, et al. Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan. DEN open. 2025. 5. 1. e371
Satoshi Iwai, Takemi Akahane, Hiroaki Takaya, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Junya Suzuki, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, et al. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Nagisa Hara, Atsushi Hiraoka, Masato Nakai, Makoto Shiraki, Tadashi Namisaki, Hisamitsu Miyaaki, Takuro Hisanaga, Hirokazu Takahashi, Hideko Ohama, Fujimasa Tada, et al. Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Hideki Kunichika, Satoshi Yamauchi, Sho Shimizu, et al. Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers. 2024. 16. 9
Takahiro Kubo, Norihisa Nishimura, Kosuke Kaji, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Junya Suzuki, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, et al. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment. International journal of molecular sciences. 2024. 25. 8